Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World's Premier Cancer Research Forum

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that two research abstracts have been accepted for presentation at the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22 in San Diego, California. The AACR Annual Meeting is a global forum for ...